For example, we see a significant GWAS association between breast cancer risk and variants in the estrogen receptor (ESR1) locus even after controlling for coding variation; the baseline expression model would thus predict that non-coding risk alleles alter ESR1 expression to drive breast cancer risk. The gene discussed is ESR1; the disease is breast carcinoma.